ATEBRIOZ

Welcome to the Brand page for “ATEBRIOZ”, which is offered here for Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of graft versus host disorder (gvhd); pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of fibrotic disorders;printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building;providing a medical information to healthcare providers and patients relating to viral, hematological, auto-immune, graft versus host, inflammatory, metabolic, fibrotic and dermatological disorders;.

Its status is currently believed to be active. Its class is unavailable. “ATEBRIOZ” is believed to be currently owned by “INCYTE HOLDINGS CORPORATION”.